In vitro impairment of interleukin-5 production in HLA-B8,DR3-positive individuals implications for immunoglobulin a synthesis dysfunction

Abstract

Healthy subjects carrying the HLA-B8, DR3 haplotype may show a large number of immune dysfunctions. Concerning T-cell dysfunctions, the most intriguing is a defect of the early phases of T-cell activation, responsible for the impairment of in vitro mitogenstimulated cytokine production. Regarding B-cell dysfunctions, one the most fascinating topics is the association between this haplotype and IgA deficiency in healthy blood donors. Accordingly, HLA-B8, DR3-positive healthy subjects show significantly lower values of serum IgA than HLA-B8, DR3-negative ones. Because IL-5 is a stimulating factor for the secretion of IgA by committed B cells, we have analyzed the in vitro mitogen-stimulated IL-5 production by MNCs from healthy HLA-B8,DR3-positive individuals to study whether they display an impaired production of IL-5. The results clearly demonstrate that MNCs from HLA-B8, DR3-positive individuals display significant reduction of IL-5 production, suggesting that IgA synthesis dysregulation observed in HLA-B8, DR3-positive subjects could be due to an impairment of IL-5 production.